Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

Prestroke statins, progression of white matter hyperintensities, and cognitive decline in stroke patients with confluent white matter hyperintensities.

Xiong Y, Wong A, Cavalieri M, Schmidt R, Chu WW, Liu X, Wong KS, Mok V.

Neurotherapeutics. 2014 Jul;11(3):606-11. doi: 10.1007/s13311-014-0270-5.

2.

Predictors for cognitive decline in patients with confluent white matter hyperintensities.

Mok V, Xiong Y, Wong KK, Wong A, Schmidt R, Chu WW, Hu X, Lung Leung EY, Chen S, Chen Y, Tang WK, Chen X, Ho CL, Wong KS, Wong ST.

Alzheimers Dement. 2012 Oct;8(5 Suppl):S96-S103. doi: 10.1016/j.jalz.2011.10.004. Epub 2012 May 30.

PMID:
22651941
3.

Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.

Molad J, Kliper E, Korczyn AD, Ben Assayag E, Ben Bashat D, Shenhar-Tsarfaty S, Aizenstein O, Shopin L, Bornstein NM, Auriel E.

J Alzheimers Dis. 2017;56(4):1293-1299. doi: 10.3233/JAD-160939.

PMID:
28157096
4.

Baseline characteristic of patients presenting with lacunar stroke and cerebral small vessel disease may predict future development of depression.

Pavlovic AM, Pekmezovic T, Zidverc Trajkovic J, Svabic Medjedovic T, Veselinovic N, Radojicic A, Mijajlovic M, Tomic G, Jovanovic Z, Norton M, Sternic N.

Int J Geriatr Psychiatry. 2016 Jan;31(1):58-65. doi: 10.1002/gps.4289. Epub 2015 Mar 27.

PMID:
25821003
5.

Baseline predictors of cognitive decline in patients with cerebral small vessel disease.

Pavlovic AM, Pekmezovic T, Tomic G, Trajkovic JZ, Sternic N.

J Alzheimers Dis. 2014;42 Suppl 3:S37-43. doi: 10.3233/JAD-132606.

PMID:
24898641
6.

White matter integrity in small vessel disease is related to cognition.

Tuladhar AM, van Norden AG, de Laat KF, Zwiers MP, van Dijk EJ, Norris DG, de Leeuw FE.

Neuroimage Clin. 2015 Feb 16;7:518-24. doi: 10.1016/j.nicl.2015.02.003. eCollection 2015.

7.

Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease.

Zeestraten EA, Lawrence AJ, Lambert C, Benjamin P, Brookes RL, Mackinnon AD, Morris RG, Barrick TR, Markus HS.

Neurology. 2017 Oct 31;89(18):1869-1876. doi: 10.1212/WNL.0000000000004594. Epub 2017 Oct 4.

8.

Association between Perivascular Spaces and Progression of White Matter Hyperintensities in Lacunar Stroke Patients.

Loos CM, Klarenbeek P, van Oostenbrugge RJ, Staals J.

PLoS One. 2015 Sep 9;10(9):e0137323. doi: 10.1371/journal.pone.0137323. eCollection 2015.

9.

White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.

Nolze-Charron G, Mouiha A, Duchesne S, Bocti C; Alzheimer's Disease Neuroimaging Initiative1.

J Alzheimers Dis. 2015;46(4):855-62. doi: 10.3233/JAD-140618.

PMID:
26402625
10.

Race-ethnicity and cerebral small vessel disease--comparison between Chinese and White populations.

Mok V, Srikanth V, Xiong Y, Phan TG, Moran C, Chu S, Zhao Q, Chu WW, Wong A, Hong Z, Liu X, Wong LK, Ding D.

Int J Stroke. 2014 Oct;9 Suppl A100:36-42. doi: 10.1111/ijs.12270. Epub 2014 Mar 24.

PMID:
24661839
11.

MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.

Uiterwijk R, Staals J, Huijts M, de Leeuw PW, Kroon AA, van Oostenbrugge RJ.

J Hypertens. 2017 Jun;35(6):1263-1270. doi: 10.1097/HJH.0000000000001294.

PMID:
28169884
12.

Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.

van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, Schmidt R, Fazekas F, Scheltens P.

Stroke. 2005 Oct;36(10):2116-20. Epub 2005 Sep 1.

13.

Cerebral microbleeds are not associated with long-term cognitive outcome in patients with transient ischemic attack or minor stroke.

Brundel M, Kwa VI, Bouvy WH, Algra A, Kappelle LJ, Biessels GJ; MICRO Study Group.

Cerebrovasc Dis. 2014;37(3):195-202. doi: 10.1159/000358119. Epub 2014 Feb 19.

PMID:
24557016
14.

MRI-visible perivascular spaces: relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA.

Hurford R, Charidimou A, Fox Z, Cipolotti L, Jager R, Werring DJ.

J Neurol Neurosurg Psychiatry. 2014 May;85(5):522-5. doi: 10.1136/jnnp-2013-305815. Epub 2013 Nov 18.

15.

Impact of Strategically Located White Matter Hyperintensities on Cognition in Memory Clinic Patients with Small Vessel Disease.

Biesbroek JM, Weaver NA, Hilal S, Kuijf HJ, Ikram MK, Xu X, Tan BY, Venketasubramanian N, Postma A, Biessels GJ, Chen CP.

PLoS One. 2016 Nov 8;11(11):e0166261. doi: 10.1371/journal.pone.0166261. eCollection 2016.

16.

The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.

Sunwoo MK, Jeon S, Ham JH, Hong JY, Lee JE, Lee JM, Sohn YH, Lee PH.

Eur J Neurol. 2014 Jun;21(6):922-e50. doi: 10.1111/ene.12412. Epub 2014 Mar 24.

PMID:
24661277
17.

Longitudinal relationship between cerebral small-vessel disease and cerebral blood flow: the second manifestations of arterial disease-magnetic resonance study.

van der Veen PH, Muller M, Vincken KL, Hendrikse J, Mali WP, van der Graaf Y, Geerlings MI; SMART Study Group.

Stroke. 2015 May;46(5):1233-8. doi: 10.1161/STROKEAHA.114.008030. Epub 2015 Mar 24.

18.

Relationship between white matter hyperintensities, cortical thickness, and cognition.

Tuladhar AM, Reid AT, Shumskaya E, de Laat KF, van Norden AG, van Dijk EJ, Norris DG, de Leeuw FE.

Stroke. 2015 Feb;46(2):425-32. doi: 10.1161/STROKEAHA.114.007146. Epub 2015 Jan 8.

19.

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.

Kester MI, Goos JD, Teunissen CE, Benedictus MR, Bouwman FH, Wattjes MP, Barkhof F, Scheltens P, van der Flier WM.

JAMA Neurol. 2014 Jul 1;71(7):855-62. doi: 10.1001/jamaneurol.2014.754.

PMID:
24818585
20.

Nonlinear temporal dynamics of cerebral small vessel disease: The RUN DMC study.

van Leijsen EMC, van Uden IWM, Ghafoorian M, Bergkamp MI, Lohner V, Kooijmans ECM, van der Holst HM, Tuladhar AM, Norris DG, van Dijk EJ, Rutten-Jacobs LCA, Platel B, Klijn CJM, de Leeuw FE.

Neurology. 2017 Oct 10;89(15):1569-1577. doi: 10.1212/WNL.0000000000004490. Epub 2017 Sep 6.

Supplemental Content

Support Center